{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:33:01Z","timestamp":1793975581408,"version":"4.8.0"},"reference-count":109,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006224","name":"Argonne National Laboratory","doi-asserted-by":"publisher","award":["S10_RR028976"],"award-info":[{"award-number":["S10_RR028976"]}],"id":[{"id":"10.13039\/100006224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006224","name":"Argonne National Laboratory","doi-asserted-by":"publisher","award":["S10_RR25528"],"award-info":[{"award-number":["S10_RR25528"]}],"id":[{"id":"10.13039\/100006224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006224","name":"Argonne National Laboratory","doi-asserted-by":"publisher","award":["S10_OD027000"],"award-info":[{"award-number":["S10_OD027000"]}],"id":[{"id":"10.13039\/100006224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AID-GH-T-15-00001"],"award-info":[{"award-number":["AID-GH-T-15-00001"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10_RR25528"],"award-info":[{"award-number":["S10_RR25528"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10_RR028976"],"award-info":[{"award-number":["S10_RR028976"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10_OD027000"],"award-info":[{"award-number":["S10_OD027000"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006132","name":"Office of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006151","name":"Basic Energy Sciences","doi-asserted-by":"publisher","award":["W-31-109-Eng-38"],"award-info":[{"award-number":["W-31-109-Eng-38"]}],"id":[{"id":"10.13039\/100006151","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.xcrm.2025.101985","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T15:34:24Z","timestamp":1740670464000},"page":"101985","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["A strain-transcending anti-AMA1 human monoclonal antibody neutralizes malaria parasites independent of direct RON2L receptor blockade"],"prefix":"10.1016","volume":"6","author":[{"given":"Palak N.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ababacar","family":"Diouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thayne H.","family":"Dickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai Kwan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine S.","family":"Hopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boubacar","family":"Traore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole A.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoyo","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Crompton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niraj H.","family":"Tolia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.101985_bib1","series-title":"World Malaria Report","year":"2023"},{"key":"10.1016\/j.xcrm.2025.101985_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial","volume":"386","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2025.101985_bib3","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/S0140-6736(21)00943-0","article-title":"Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial","volume":"397","author":"Datoo","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2025.101985_bib4","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa2026330","article-title":"Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention","volume":"385","author":"Chandramohan","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.101985_bib5","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa1505819","article-title":"Genetic Diversity and Protective Efficacy of the RTS,S\/AS01 Malaria Vaccine","volume":"373","author":"Neafsey","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.101985_bib6","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMoa2034031","article-title":"A Monoclonal Antibody for Malaria Prevention","volume":"385","author":"Gaudinski","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.101985_bib7","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1056\/NEJMoa2206966","article-title":"Safety and Efficacy of a Monoclonal Antibody against Malaria in Mali","volume":"387","author":"Kayentao","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.101985_bib8","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S1473-3099(22)00793-9","article-title":"Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial","volume":"23","author":"Lyke","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.xcrm.2025.101985_bib9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1056\/NEJMoa2203067","article-title":"Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria","volume":"387","author":"Wu","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.101985_bib10","first-page":"3151","article-title":"Integral Membrane Protein Located in the Apical Complex of Plasmodium falciparum","volume":"9","author":"Peterson","year":"1989","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2025.101985_bib11","doi-asserted-by":"crossref","first-page":"29446","DOI":"10.1074\/jbc.271.46.29446","article-title":"The Disulfide Bond Structure of Plasmodium Apical Membrane Antigen-1","volume":"271","author":"Hodder","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2025.101985_bib12","doi-asserted-by":"crossref","first-page":"31311","DOI":"10.1074\/jbc.M103076200","article-title":"Proteolytic Processing and Primary Structure of Plasmodium falciparum Apical Membrane Antigen-1","volume":"276","author":"Howell","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2025.101985_bib13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1083\/jcb.77.1.72","article-title":"Erythrocyte entry by malarial parasites. A moving junction between erythrocyte and parasite","volume":"77","author":"Aikawa","year":"1978","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.xcrm.2025.101985_bib14","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/cmi.12287","article-title":"Conditional expression of apical membrane antigen 1 in Plasmodium falciparum shows it is required for erythrocyte invasion by merozoites","volume":"16","author":"Yap","year":"2014","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.xcrm.2025.101985_bib15","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1038\/ncomms5098","article-title":"Plasticity and redundancy among AMA\u2013RON pairs ensure host cell entry of Toxoplasma parasites","volume":"5","author":"Lamarque","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.101985_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010643","article-title":"The AMA1-RON complex drives Plasmodium sporozoite invasion in the mosquito and mammalian hosts","volume":"18","author":"Fernandes","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2025.101985_bib17","doi-asserted-by":"crossref","first-page":"9490","DOI":"10.1074\/jbc.M311331200","article-title":"A Role for Apical Membrane Antigen 1 during Invasion of Hepatocytes by Plasmodium falciparum Sporozoites","volume":"279","author":"Silvie","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2025.101985_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.chom.2010.12.003","article-title":"Super-Resolution Dissection of Coordinated Events during Malaria Parasite Invasion of the Human Erythrocyte","volume":"9","author":"Riglar","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.xcrm.2025.101985_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.parint.2008.09.005","article-title":"Rhoptry neck protein RON2 forms a complex with microneme protein AMA1 in Plasmodium falciparum merozoites","volume":"58","author":"Cao","year":"2009","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.xcrm.2025.101985_bib20","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1462-5822.2011.01597.x","article-title":"The moving junction of apicomplexan parasites: a key structure for invasion","volume":"13","author":"Besteiro","year":"2011","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.xcrm.2025.101985_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000309","article-title":"Export of a Toxoplasma gondii Rhoptry Neck Protein Complex at the Host Cell Membrane to Form the Moving Junction during Invasion","volume":"5","author":"Besteiro","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2025.101985_bib22","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1126\/science.1204988","article-title":"Host Cell Invasion by Apicomplexan Parasites: Insights from the Co-Structure of AMA1 with a RON2 Peptide","volume":"333","author":"Tonkin","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.101985_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002755","article-title":"Structural and Functional Insights into the Malaria Parasite Moving Junction Complex","volume":"8","author":"Vulliez-Le Normand","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2025.101985_bib24","article-title":"Structure of the Malaria Antigen AMA1 in Complex with a Growth-Inhibitory Antibody","volume":"3","author":"Coley","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2025.101985_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003840","article-title":"Overcoming Antigenic Diversity by Enhancing the Immunogenicity of Conserved Epitopes on the Malaria Vaccine Candidate Apical Membrane Antigen-1","volume":"9","author":"Dutta","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2025.101985_bib26","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.str.2007.09.011","article-title":"Structure of an IgNAR-AMA1 Complex: Targeting a Conserved Hydrophobic Cleft Broadens Malarial Strain Recognition","volume":"15","author":"Henderson","year":"2007","journal-title":"Structure"},{"key":"10.1016\/j.xcrm.2025.101985_bib27","doi-asserted-by":"crossref","first-page":"15119","DOI":"10.1074\/jbc.273.24.15119","article-title":"Precise Timing of Expression of a Plasmodium falciparum- derived Transgene in Plasmodium berghei Is a Critical Determinant of Subsequent Subcellular Localization","volume":"273","author":"Kocken","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2025.101985_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/srep39462","article-title":"Characterization of a novel inhibitory human monoclonal antibody directed against Plasmodium falciparum Apical Membrane Antigen 1","volume":"6","author":"Maskus","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2025.101985_bib29","doi-asserted-by":"crossref","first-page":"12295","DOI":"10.1073\/pnas.2032858100","article-title":"Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of Plasmodium falciparum merozoites","volume":"100","author":"Dutta","year":"2003","journal-title":"Proc. Natl.\u00a0Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.101985_bib30","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0264-410X(97)88331-4","article-title":"Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi","volume":"16","author":"Anders","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.xcrm.2025.101985_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008138","article-title":"High Antibody Titer against Apical Membrane Antigen-1 Is Required to Protect against Malaria in the Aotus Model","volume":"4","author":"Dutta","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2025.101985_bib32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41541-017-0015-7","article-title":"A malaria vaccine protects Aotus monkeys against virulent Plasmodium falciparum infection","volume":"2","author":"Srinivasan","year":"2017","journal-title":"npj Vaccines"},{"key":"10.1016\/j.xcrm.2025.101985_bib33","doi-asserted-by":"crossref","first-page":"10311","DOI":"10.1073\/pnas.1409928111","article-title":"Immunization with a functional protein complex required for erythrocyte invasion protects against lethal malaria","volume":"111","author":"Srinivasan","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.101985_bib34","doi-asserted-by":"crossref","first-page":"6961","DOI":"10.1128\/IAI.70.12.6961-6967.2002","article-title":"Vaccination of Monkeys with Recombinant Plasmodium falciparum Apical Membrane Antigen 1 Confers Protection against Blood-Stage Malaria","volume":"70","author":"Stowers","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.xcrm.2025.101985_bib35","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1128\/IAI.70.6.3101-3110.2002","article-title":"Purification, Characterization, and Immunogenicity of the Refolded Ectodomain of the Plasmodium falciparum Apical Membrane Antigen 1 Expressed in Escherichia coli","volume":"70","author":"Dutta","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.xcrm.2025.101985_bib36","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1016\/j.vaccine.2007.03.012","article-title":"Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-na\u00efve adults at the Walter Reed Army Institute of Research","volume":"25","author":"Polhemus","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.xcrm.2025.101985_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005254","article-title":"Phase 1\/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A","volume":"4","author":"Spring","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2025.101985_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001465","article-title":"Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial","volume":"3","author":"Thera","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2025.101985_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009041","article-title":"Safety and Immunogenicity of an AMA1 Malaria Vaccine in Malian Children: Results of a Phase 1 Randomized Controlled Trial","volume":"5","author":"Thera","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2025.101985_bib40","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJMoa1008115","article-title":"A Field Trial to Assess a Blood-Stage Malaria Vaccine","volume":"365","author":"Thera","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.101985_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015391","article-title":"Generation of Humoral Immune Responses to Multi-Allele PfAMA1 Vaccines; Effect of Adjuvant and Number of Component Alleles on the Breadth of Response","volume":"5","author":"Kusi","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2025.101985_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008110","article-title":"Humoral Immune Response to Mixed PfAMA1 Alleles; Multivalent PfAMA1 Vaccines Induce Broad Specificity","volume":"4","author":"Kusi","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2025.101985_bib43","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1475-2875-10-40","article-title":"Immunization with different Pf AMA1 alleles in sequence induces clonal imprint humoral responses that are similar to responses induced by the same alleles as a vaccine cocktail in rabbits","volume":"10","author":"Kusi","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.xcrm.2025.101985_bib44","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1128\/IAI.01414-12","article-title":"Overcoming Allelic Specificity by Immunization with Five Allelic Forms of Plasmodium falciparum Apical Membrane Antigen 1","volume":"81","author":"Miura","year":"2013","journal-title":"Infect. Immun."},{"key":"10.1016\/j.xcrm.2025.101985_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00743","article-title":"Immunization with the Malaria Diversity-Covering Blood-Stage Vaccine Candidate Plasmodium falciparum Apical Membrane Antigen 1 DiCo in Complex with Its Natural Ligand Pf Ron2 Does Not Improve the In\u00a0Vitro Efficacy","volume":"8","author":"Spiegel","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.101985_bib46","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/biot.201500055","article-title":"The stage-specific in\u00a0vitro efficacy of a malaria antigen cocktail provides valuable insights into the development of effective multi-stage vaccines","volume":"10","author":"Spiegel","year":"2015","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.xcrm.2025.101985_bib47","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/infdis\/jis709","article-title":"Molecular Basis of Allele-Specific Efficacy of a Blood-Stage Malaria Vaccine: Vaccine Development Implications","volume":"207","author":"Ouattara","year":"2013","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2025.101985_bib48","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/infdis\/jiw039","article-title":"Demonstration of the Blood-Stage Plasmodium falciparum Controlled Human Malaria Infection Model to Assess Efficacy of the P. falciparum Apical Membrane Antigen 1 Vaccine, FMP2.1\/AS01","volume":"213","author":"Payne","year":"2016","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2025.101985_bib49","doi-asserted-by":"crossref","first-page":"5345","DOI":"10.1038\/s41467-023-40878-7","article-title":"Structure-based design of a strain transcending AMA1-RON2L malaria vaccine","volume":"14","author":"Patel","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.101985_bib50","doi-asserted-by":"crossref","first-page":"5879","DOI":"10.1038\/s41467-023-41636-5","article-title":"Structure guided mimicry of an essential P. falciparum receptor-ligand complex enhances cross neutralizing antibodies","volume":"14","author":"Yanik","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.101985_bib51","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200901","article-title":"Plasmodium falciparum\u2013specific IgM B cells dominate in children, expand with malaria, and produce functional IgM","volume":"218","author":"Hopp","year":"2021","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2025.101985_bib52","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/cid\/cit174","article-title":"An Intensive Longitudinal Cohort Study of Malian Children and Adults Reveals No Evidence of Acquired Immunity to Plasmodium falciparum Infection","volume":"57","author":"Tran","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.xcrm.2025.101985_bib53","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1038\/s41467-022-33336-3","article-title":"Neutralizing and interfering human antibodies define the structural and mechanistic basis for antigenic diversion","volume":"13","author":"Patel","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.101985_bib54","doi-asserted-by":"crossref","first-page":"W503","DOI":"10.1093\/nar\/gkn316","article-title":"IMGT\/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis","volume":"36","author":"Brochet","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.101985_bib55","article-title":"IMGT\/V-QUEST: IMGT Standardized Analysis of the Immunoglobulin (IG) and T Cell Receptor (TR) Nucleotide Sequences","volume":"2011","author":"Giudicelli","year":"2011","journal-title":"Cold Spring Harb. Protoc."},{"key":"10.1016\/j.xcrm.2025.101985_bib56","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1126\/science.abd0827","article-title":"Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail","volume":"369","author":"Hansen","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.101985_bib57","doi-asserted-by":"crossref","first-page":"7310","DOI":"10.1021\/bi5012089","article-title":"Structure and Dynamics of Apical Membrane Antigen 1 from Plasmodium falciparum FVO","volume":"53","author":"Lim","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.xcrm.2025.101985_bib58","doi-asserted-by":"crossref","first-page":"12736","DOI":"10.1073\/pnas.0501808102","article-title":"Structure of AMA1 from Plasmodium falciparum reveals a clustering of polymorphisms that surround a conserved hydrophobic pocket","volume":"102","author":"Bai","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.101985_bib59","doi-asserted-by":"crossref","first-page":"7206","DOI":"10.1038\/s41467-024-50770-7","article-title":"A broadly cross-reactive i-body to AMA1 potently inhibits blood and liver stages of Plasmodium parasites","volume":"15","author":"Angage","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.101985_bib60","doi-asserted-by":"crossref","first-page":"7431","DOI":"10.1074\/jbc.M610562200","article-title":"Fine Mapping of an Epitope Recognized by an Invasion-inhibitory Monoclonal Antibody on the Malaria Vaccine Candidate Apical Membrane Antigen 1","volume":"282","author":"Collins","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2025.101985_bib61","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1128\/IAI.70.8.4471-4476.2002","article-title":"High-Level Expression of the Malaria Blood-Stage Vaccine Candidate Plasmodium falciparum Apical Membrane Antigen 1 and Induction of Antibodies That Inhibit Erythrocyte Invasion","volume":"70","author":"Kocken","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.xcrm.2025.101985_bib62","doi-asserted-by":"crossref","DOI":"10.12688\/wellcomeopenres.16168.1","article-title":"An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples","volume":"6","author":"MalariaGEN","year":"2021","journal-title":"Wellcome Open Res."},{"key":"10.1016\/j.xcrm.2025.101985_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67877-8","article-title":"Bliss' and Loewe's additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinations","volume":"10","author":"Azasi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2025.101985_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001276","article-title":"The RON2-AMA1 Interaction is a Critical Step in Moving Junction-Dependent Invasion by Apicomplexan Parasites","volume":"7","author":"Lamarque","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2025.101985_bib65","doi-asserted-by":"crossref","unstructured":"Foley, M., Angage, D., Anders, R., Chmielewski, J., Maddumage, J., Hesping, E., Caiazzo, S., Lai, K.H., Yeoh, L., Opi, H., et\u00a0al. (2023). A broadly cross-reactive i-body to AMA1 potently inhibits blood and liver stages of Plasmodium parasites. https:\/\/doi.org\/10.21203\/rs.3.rs-3671797\/v1.","DOI":"10.21203\/rs.3.rs-3671797\/v1"},{"key":"10.1016\/j.xcrm.2025.101985_bib66","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1128\/IAI.73.4.2116-2122.2005","article-title":"Mode of Action of Invasion-Inhibitory Antibodies Directed against Apical Membrane Antigen 1 of Plasmodium falciparum","volume":"73","author":"Dutta","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.xcrm.2025.101985_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002448","article-title":"Juxtamembrane Shedding of Plasmodium falciparum AMA1 Is Sequence Independent and Essential, and Helps Evade Invasion-Inhibitory Antibodies","volume":"7","author":"Olivieri","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2025.101985_bib68","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12936-020-03548-3","article-title":"Isolation and light chain shuffling of a Plasmodium falciparum AMA1-specific human monoclonal antibody with growth inhibitory activity","volume":"20","author":"Seidel-Greven","year":"2021","journal-title":"Malar. J."},{"key":"10.1016\/j.xcrm.2025.101985_bib69","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2958.2003.03974.x","article-title":"Allelic polymorphisms in apical membrane antigen-1 are responsible for evasion of antibody-mediated inhibition in Plasmodium falciparum","volume":"52","author":"Healer","year":"2004","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.xcrm.2025.101985_bib70","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/genetics\/165.2.555","article-title":"Allele Frequency-Based Analyses Robustly Map Sequence Sites Under Balancing Selection in a Malaria Vaccine Candidate Antigen","volume":"165","author":"Polley","year":"2003","journal-title":"Genetics"},{"key":"10.1016\/j.xcrm.2025.101985_bib71","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/genetics\/158.4.1505","article-title":"Strong Diversifying Selection on Domains of the Plasmodium falciparum Apical Membrane Antigen 1 Gene","volume":"158","author":"Polley","year":"2001","journal-title":"Genetics"},{"key":"10.1016\/j.xcrm.2025.101985_bib72","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cell.2019.05.025","article-title":"Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies","volume":"178","author":"Alanine","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.101985_bib73","doi-asserted-by":"crossref","first-page":"12045","DOI":"10.1073\/pnas.1702944114","article-title":"Synergistic malaria vaccine combinations identified by systematic antigen screening","volume":"114","author":"Bustamante","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.101985_bib74","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.3389\/fimmu.2019.01254","article-title":"Functional Comparison of Blood-Stage Plasmodium falciparum Malaria Vaccine Candidate Antigens","volume":"10","author":"Illingworth","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.101985_bib75","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1126\/science.aar5304","article-title":"Antihomotypic affinity maturation improves human B cell responses against a repetitive epitope","volume":"360","author":"Imkeller","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.101985_bib76","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aau8529","article-title":"Cryo-EM structure of P. falciparum circumsporozoite protein with a vaccine-elicited antibody is stabilized by somatically mutated inter-Fab contacts","volume":"4","author":"Oyen","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2025.101985_bib77","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s41467-021-21221-4","article-title":"Structural and biophysical correlation of anti-NANP antibodies with in\u00a0vivo protection against P. falciparum","volume":"12","author":"Pholcharee","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.101985_bib78","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s41467-022-28601-4","article-title":"Heterotypic interactions drive antibody synergy against a malaria vaccine candidate","volume":"13","author":"Ragotte","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.101985_bib79","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.immuni.2020.01.001","article-title":"Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization","volume":"52","author":"Gilchuk","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2025.101985_bib80","doi-asserted-by":"crossref","first-page":"E82","DOI":"10.1073\/pnas.1718441115","article-title":"Synergistic anti-HCV broadly neutralizing human monoclonal antibodies with independent mechanisms","volume":"115","author":"Mankowski","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.101985_bib81","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1126\/science.aaz9356","article-title":"Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab","volume":"367","author":"Roug\u00e9","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.101985_bib82","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1128\/jvi.70.7.4466-4473.1996","article-title":"Synergistic neutralization of human immunodeficiency virus type 1 by a chimpanzee monoclonal antibody against the V2 domain of gp120 in combination with monoclonal antibodies against the V3 loop and the CD4-binding site","volume":"70","author":"Vijh-Warrier","year":"1996","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2025.101985_bib83","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1038\/s41467-023-38509-2","article-title":"Structural basis of epitope selectivity and potent protection from malaria by PfCSP antibody L9","volume":"14","author":"Martin","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.101985_bib84","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41591-023-02659-z","article-title":"A candidate antibody drug for prevention of malaria","volume":"30","author":"Williams","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.101985_bib85","doi-asserted-by":"crossref","first-page":"4964","DOI":"10.1016\/j.cell.2024.06.015","article-title":"Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype","volume":"187","author":"Barrett","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.101985_bib86","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1016\/j.cell.2024.06.037","article-title":"Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5","volume":"187","author":"Wang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.101985_bib87","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","article-title":"XDS","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"10.1016\/j.xcrm.2025.101985_bib88","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1107\/S0907444913000061","article-title":"How good are my data and what is the resolution?","volume":"69","author":"Evans","year":"2013","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"10.1016\/j.xcrm.2025.101985_bib89","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1107\/S2059798319011471","article-title":"Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix","volume":"75","author":"Liebschner","year":"2019","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.xcrm.2025.101985_bib90","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. D"},{"key":"10.1016\/j.xcrm.2025.101985_bib91","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J.\u00a0Appl. Crystallogr."},{"key":"10.1016\/j.xcrm.2025.101985_bib92","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1107\/S0907444905001617","article-title":"Likelihood-enhanced fast translation functions","volume":"61","author":"McCoy","year":"2005","journal-title":"Acta Crystallogr D Biol Crystallogr."},{"key":"10.1016\/j.xcrm.2025.101985_bib93","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1107\/S090744490705024X","article-title":"Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard","volume":"64","author":"Terwilliger","year":"2008","journal-title":"Acta Crystallogr D Biol Crystallogr."},{"key":"10.1016\/j.xcrm.2025.101985_bib94","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr."},{"key":"10.1016\/j.xcrm.2025.101985_bib95","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1107\/S0907444912001308","article-title":"Towards automated crystallographic structure refinement with phenix.refine","volume":"68","author":"Afonine","year":"2012","journal-title":"Acta Crystallogr D Biol Crystallogr."},{"key":"10.1016\/j.xcrm.2025.101985_bib96","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr."},{"key":"10.1016\/j.xcrm.2025.101985_bib97","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/pro.3330","article-title":"MolProbity: More and better reference data for improved all-atom structure validation","volume":"27","author":"Williams","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.xcrm.2025.101985_bib98","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.01456","article-title":"Collaboration gets the most out of software","volume":"2","author":"Morin","year":"2013","journal-title":"Elife"},{"key":"10.1016\/j.xcrm.2025.101985_bib99","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.immuni.2019.06.024","article-title":"Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B cell Responses to Influenza Hemagglutinin","volume":"51","author":"Andrews","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2025.101985_bib100","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","article-title":"Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning","volume":"329","author":"Tiller","year":"2008","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.xcrm.2025.101985_bib101","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1107\/S0907444906029799","article-title":"A time- and cost-efficient system for high-level protein production in mammalian cells","volume":"62","author":"Aricescu","year":"2006","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.xcrm.2025.101985_bib102","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/msb.2011.75","article-title":"Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega","volume":"7","author":"Sievers","year":"2011","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.xcrm.2025.101985_bib103","doi-asserted-by":"crossref","first-page":"W320","DOI":"10.1093\/nar\/gku316","article-title":"Deciphering key features in protein structures with the new ENDscript server","volume":"42","author":"Robert","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.101985_bib104","series-title":"The Proteomics Protocols Handbook","first-page":"571","article-title":"Protein Identification and Analysis Tools on the ExPASy Server","author":"Gasteiger","year":"2005"},{"key":"10.1016\/j.xcrm.2025.101985_bib105","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1101\/gr.7187808","article-title":"Large-scale screening for novel low-affinity extracellular protein interactions","volume":"18","author":"Bushell","year":"2008","journal-title":"Genome Res."},{"key":"10.1016\/j.xcrm.2025.101985_bib106","series-title":"Site-Specific Protein Labeling: Methods and Protocols","first-page":"171","article-title":"Site-Specific Biotinylation of Purified Proteins Using BirA","author":"Fairhead","year":"2015"},{"key":"10.1016\/j.xcrm.2025.101985_bib107","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1107\/S0907444900014736","article-title":"Use of TLS parameters to model anisotropic displacements in macromolecular refinement","volume":"57","author":"Winn","year":"2001","journal-title":"Acta Crystallogr D Biol Crystallogr."},{"key":"10.1016\/j.xcrm.2025.101985_bib108","doi-asserted-by":"crossref","first-page":"eabq8276","DOI":"10.1126\/sciadv.abq8276","article-title":"Design of the SARS-CoV-2 RBD vaccine antigen improves neutralizing antibody response","volume":"8","author":"Dickey","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2025.101985_bib109","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1128\/CVI.00042-09","article-title":"Anti-Apical-Membrane-Antigen-1 Antibody Is More Effective than Anti-42-Kilodalton-Merozoite-Surface-Protein-1 Antibody in Inhibiting Plasmodium falciparum Growth, as Determined by the In\u00a0Vitro Growth Inhibition Assay","volume":"16","author":"Miura","year":"2009","journal-title":"Clin. Vaccine Immunol."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125000588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125000588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T18:31:05Z","timestamp":1745001065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379125000588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":109,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2666379125000588"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.101985","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A strain-transcending anti-AMA1 human monoclonal antibody neutralizes malaria parasites independent of direct RON2L receptor blockade","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.101985","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101985"}}